JavaScript is disabled in your browser. Please enable JavaScript to view this website.
AB317678

Recombinant Human Androgen receptor (Isoform 3) Protein Standard (His tag)

Be the first to review this product! Submit a review

|

(0 Publication)

Recombinant Human Androgen receptor (Isoform 3) Protein Standard (His tag) AB317678 is a Human Fragment protein expressed in Escherichia coli suitable for SDS-PAGE, sELISA.

- Localization: Intracellular

- Proximate region: C-terminus

- His tag C-Terminus

- >80% SDS-PAGE

View Alternative Names

DHTR, NR3C4, AR, Androgen receptor, Dihydrotestosterone receptor, Nuclear receptor subfamily 3 group C member 4

2 Images
Sandwich ELISA - Recombinant Human Androgen receptor (Isoform 3) Protein Standard (His tag) (AB317678)
  • sELISA

Lab

Sandwich ELISA - Recombinant Human Androgen receptor (Isoform 3) Protein Standard (His tag) (AB317678)

Sandwich ELISA with the capture antibody ab285025 dilution at 2 μg/mL and detector antibody ab285131 dilution at 0.5 μg/mL after biotin conjugation.

SDS-PAGE - Recombinant Human Androgen receptor (Isoform 3) Protein Standard (His tag) (AB317678)
  • SDS-PAGE

Lab

SDS-PAGE - Recombinant Human Androgen receptor (Isoform 3) Protein Standard (His tag) (AB317678)

SDS-PAGE analysis of ab317678 under reducing conditions for 2ug protein.

Key facts

Purity

>80% SDS-PAGE

Expression system

Escherichia coli

Tags

His tag C-Terminus

Applications

SDS-PAGE, sELISA

applications

Biologically active

No

Accession

P10275

Animal free

Yes

Carrier free

No

Species

Human

Storage buffer

pH: 7.3 - 7.5 Constituents: 12.6% Glycerol (glycerin, glycerine), 2.922% Sodium chloride, 1.742% L-Arginine, 0.64107% disodium;hydrogen phosphate;dodecahydrate, 0.02858% Potassium phosphate monobasic

storage-buffer

Reactivity data

{ "title": "Reactivity Data", "filters": { "stats": ["", "Reactivity", "Dilution Info", "Notes"] }, "values": { "SDS-PAGE": { "reactivity":"TESTED_AND_REACTS", "dilution-info":"", "notes":"<p></p>" }, "sELISA": { "reactivity":"TESTED_AND_REACTS", "dilution-info":"", "notes":"<p></p>" } } }

Product details

While the standard is the same as the one provided in the corresponding SimpleStep ELISA Kit, it cannot be treated as the consumable provided with our SimpleStep ELISA Kit due to differences in its concentration calibration.

Abcam guarantee that this protein standard is suitable for use in a sandwich ELISA. Individual results may vary due to differences in technique, laboratory equipment, buffers, and other experimental factors. The detection range provided for this protein standard is based on initial sandwich ELISA validation data.

The protein concentration is the concentration after validation on our sandwich ELISA platform.

Sequence info

[{"linker":null,"sequence":null,"proteinLength":"Fragment","predictedMolecularWeight":"14.7 kDa","actualMolecularWeight":null,"aminoAcidEnd":0,"aminoAcidStart":0,"nature":"Recombinant","expressionSystem":"Escherichia coli","accessionNumber":"P10275","tags":[{"tag":"His","terminus":"C-Terminus"}]}]

Properties and storage information

Form
Liquid
Purification technique
Affinity purification His Tag
Shipped at conditions
Dry Ice
Appropriate short-term storage conditions
-80°C
Appropriate long-term storage conditions
-80°C
Aliquoting information
Upon delivery aliquot
Storage information
Avoid freeze / thaw cycle
False

Supplementary information

This supplementary information is collated from multiple sources and compiled automatically.

AR-V7 also known as Androgen Receptor Splice Variant 7 is a 75 kDa protein. It is a variant of the full-length androgen receptor (AR) but lacks the ligand-binding domain due to alternative splicing. This characteristic allows AR-V7 to remain active even in the absence of androgens making it mechanistically significant. AR-V7 expression occurs mainly in prostate tissues where the AR is fundamental to normal and cancerous growth but AR-V7 is also reported in other tissues at much lower levels.
Biological function summary

The AR-V7 contributes to the regulation of genes typically involved in cell growth and survival. AR-V7 operates as part of the androgen receptor complex which translocates into the nucleus to influence gene transcription. Due to its persistent activity AR-V7 can drive the expression of androgen-responsive genes which contributes to the proliferation of cells even in low androgen environments. This activity shows why AR-V7 presence creates therapeutic challenges because it promotes unnecessary cell growth.

Pathways

AR-V7 interacts within the androgen signaling pathway which regulates androgen-responsive gene expression. A significant relationship exists between AR-V7 and proteins like coactivators which enhance its transcriptional activity. By bypassing the typical inhibition provided by androgen deprivation therapies (ADTs) AR-V7 sustains pathway activities leading to continued cancer cell survival and proliferation. It is also related to the Akt pathway which further supports cell survival and metabolic processes.

AR-V7 plays an important role in castration-resistant prostate cancer (CRPC) where conventional therapies targeting the androgen receptor fail. The persistent activity of AR-V7 independent of androgen binding results in resistance to ADTs including enzalutamide and abiraterone. AR-V7 expression correlates with poor clinical outcomes in CRPC patients making it a potential biomarker for resistance. Furthermore its interaction with protein elements such as full-length androgen receptors highlights its impact on driving disease progression and resistance to treatments.

General info

Function

Steroid hormone receptors are ligand-activated transcription factors that regulate eukaryotic gene expression and affect cellular proliferation and differentiation in target tissues (PubMed : 19022849). Transcription factor activity is modulated by bound coactivator and corepressor proteins like ZBTB7A that recruits NCOR1 and NCOR2 to the androgen response elements/ARE on target genes, negatively regulating androgen receptor signaling and androgen-induced cell proliferation (PubMed : 20812024). Transcription activation is also down-regulated by NR0B2. Activated, but not phosphorylated, by HIPK3 and ZIPK/DAPK3.. Isoform 3. Lacks the C-terminal ligand-binding domain and therefore constitutively regulates the transcription of a specific set of canonical AR-target genes, including PSA/KLK3 and TMPRSS2, independently of steroid hormones (PubMed : 19244107, PubMed : 25008967). However, some genes are differentially regulated by full-length AR (isoform 1) and isoform 3. Isoform 3-specific target genes may be regulated independently of FOXA1 expression (PubMed : 25008967).. Isoform 4. Lacks the C-terminal ligand-binding domain and may therefore constitutively activate the transcription of a specific set of genes independently of steroid hormones.

Sequence similarities

Belongs to the nuclear hormone receptor family. NR3 subfamily.

Post-translational modifications

Sumoylated on Lys-388 (major) and Lys-521. Ubiquitinated. Deubiquitinated by USP26. 'Lys-6' and 'Lys-27'-linked polyubiquitination by RNF6 modulates AR transcriptional activity and specificity.. Phosphorylated in prostate cancer cells in response to several growth factors including EGF. Phosphorylation is induced by c-Src kinase (CSK). Tyr-535 is one of the major phosphorylation sites and an increase in phosphorylation and Src kinase activity is associated with prostate cancer progression. Phosphorylation by TNK2 enhances the DNA-binding and transcriptional activity and may be responsible for androgen-independent progression of prostate cancer. Phosphorylation at Ser-83 by CDK9 regulates AR promoter selectivity and cell growth. Phosphorylation by PAK6 leads to AR-mediated transcription inhibition.. Palmitoylated by ZDHHC7 and ZDHHC21. Palmitoylation is required for plasma membrane targeting and for rapid intracellular signaling via ERK and AKT kinases and cAMP generation.

Product protocols

Target data

Steroid hormone receptors are ligand-activated transcription factors that regulate eukaryotic gene expression and affect cellular proliferation and differentiation in target tissues (PubMed : 19022849). Transcription factor activity is modulated by bound coactivator and corepressor proteins like ZBTB7A that recruits NCOR1 and NCOR2 to the androgen response elements/ARE on target genes, negatively regulating androgen receptor signaling and androgen-induced cell proliferation (PubMed : 20812024). Transcription activation is also down-regulated by NR0B2. Activated, but not phosphorylated, by HIPK3 and ZIPK/DAPK3.. Isoform 3. Lacks the C-terminal ligand-binding domain and therefore constitutively regulates the transcription of a specific set of canonical AR-target genes, including PSA/KLK3 and TMPRSS2, independently of steroid hormones (PubMed : 19244107, PubMed : 25008967). However, some genes are differentially regulated by full-length AR (isoform 1) and isoform 3. Isoform 3-specific target genes may be regulated independently of FOXA1 expression (PubMed : 25008967).. Isoform 4. Lacks the C-terminal ligand-binding domain and may therefore constitutively activate the transcription of a specific set of genes independently of steroid hormones.
See full target information AR

Product promise

We are committed to supporting your work with high-quality reagents, and we're here for you every step of the way. In the unlikely event that one of our products does not perform as expected, you're protected by our Product Promise.
For full details, please see our Terms & Conditions

Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.

For licensing inquiries, please contact partnerships@abcam.com